Table 1.
Body fat ratio-associated loci that have not previously been associated with an anthropometric trait
Chr | Lead SNP | Position (bp) | MAF | Most likely target gene | Strongest associated trait | β Disc | P Disc | β Repl | P Repl | P Meta | Direction |
---|---|---|---|---|---|---|---|---|---|---|---|
chr1 | rs4971091 | 155,143,768 | 0.377 | KRTCAP2 α | AFR - combined | −0.024 | 8.23*10−8 | −0.013 | 1.35*10−5 | 3.62*10−11 | −− |
chr1 | rs180921974 | 155,268,131 | 0.023 | THBS3 δ | TFR - combined | −0.102 | 1.05*10−12 | −0.097 | 9.45*10−24 | 7.52*10−35 | −− |
chr2 | rs62107261 | 422,144 | 0.047 | FAM150B α | AFR - combined | −0.063 | 3.08*10−10 | −0.078 | 3.67*10−30 | 1.80*10−38 | −− |
chr2 | rs13011472 | 57,961,602 | 0.489 | VRK2 α | AFR - combined | −0.024 | 4.81*10−8 | −0.013 | 6.96*10−6 | 1.17*10−11 | −− |
chr2 | rs148812496 | 198,540,352 | 0.497 | RFTN α | AFR - combined | −0.03 | 2.41*10−8 | −0.015 | 4.19*10−5 | 8.07*10−11 | −− |
chr3 | rs4521268 | 49,137,904 | 0.333 | WDR6 β | TFR - combined | −0.025 | 4.30*10−8 | −0.021 | 5.00*10−12 | 1.46*10−18 | −− |
chr4 | rs2241069 | 8,602,798 | 0.461 | CPZ α | TFR - females | 0.033 | 1.56*10−8 | 0.019 | 7.86*10−7 | 3.97*10−13 | ++ |
chr5 | rs1317415 | 157,952,404 | 0.307 | RP11-32D16.1 α | LFR - females | −0.034 | 6.11*10−8 | −0.018 | 1.81*10−5 | 4.71*10−11 | −− |
chr5 | rs34022431 | 176,677,563 | 0.026 | NSD1 α | AFR - combined | 0.071 | 8.55*10−8 | 0.04 | 7.12*10−6 | 1.67*10−11 | ++ |
chr7 | rs56282717 | 150,657,095 | 0.243 | KCNH2 α | AFR - combined | −0.027 | 5.00*10−8 | −0.02 | 5.59*10−9 | 3.03*10−15 | −− |
chr8 | rs2044387 | 8,907,950 | 0.425 | ERI1 α | AFR - females | 0.035 | 1.14*10−8 | 0.024 | 1.03*10−9 | 1.69*10−16 | ++ |
chr8 | rs12546366 | 10,802,146 | 0.455 | XKR6 α | AFR - females | 0.031 | 9.29*10−8 | 0.021 | 6.50*10−8 | 8.23*10−14 | ++ |
chr9 | rs10962638 | 16,846,111 | 0.142 | BNC2 α | TFR - combined | −0.037 | 4.22*10−9 | −0.014 | 3.90*10−4 | 4.50*10−10 | −− |
chr9 | rs7039458 | 86,639,999 | 0.248 | RMI1 β, δ | TFR - females | 0.038 | 2.07*10−8 | 0.028 | 3.32*10−10 | 7.20*10−17 | ++ |
chr9 | rs3780327 | 129,945,847 | 0.22 | RALGPS1 α | LFR - combined | −0.031 | 1.95*10−9 | −0.016 | 2.50*10−6 | 3.40*10−13 | −− |
chr10 | rs34821335 | 72,433,203 | 0.273 | ADAMTS14 β | TFR - females | 0.039 | 3.40*10−9 | 0.023 | 2.22*10−7 | 2.89*10−14 | ++ |
chr10 | rs11289753 | 96,026,184 | 0.432 | PLCE1 α | AFR - combined | 0.03 | 2.41*10−12 | 0.021 | 1.60*10−12 | 1.22*10−22 | ++ |
chr11 | rs1138714 | 825,110 | 0.432 | AP006621.1 α | AFR - combined | −0.024 | 5.47*10−8 | −0.012 | 2.50*10−5 | 6.65*10−11 | −− |
chr11 | rs71455793 | 65,715,204 | 0.046 | TSGA10IP δ | TFR - females | −0.082 | 4.45*10−9 | −0.039 | 1.85*10−5 | 8.29*10−12 | −− |
chr11 | rs1789166 | 69,482,091 | 0.352 | ORAOV1 α | AFR - combined | −0.027 | 1.85*10−9 | −0.013 | 2.05*10−5 | 4.92*10−12 | −− |
chr12 | rs11614785 | 50,880,422 | 0.341 | LARP4 α | TFR - females | 0.04 | 1.37*10−10 | 0.026 | 2.93*10−10 | 1.15*10−18 | ++ |
chr14 | rs71420186 | 50,960,918 | 0.066 | MAP4K5 α | LFR - combined | −0.05 | 8.25*10−9 | −0.038 | 3.20*10−11 | 2.47*10−18 | −− |
chr15 | rs35874463 | 67,457,698 | 0.059 | SMAD3 δ | TFR - females | 0.069 | 3.58*10−8 | 0.064 | 1.44*10−14 | 3.10*10−21 | ++ |
chr15 | rs8026676 | 89,361,919 | 0.472 | RP11-343B18.2 β | TFR - females | 0.034 | 7.24*10−9 | 0.02 | 2.71*10−7 | 6.37*10−14 | ++ |
chr16 | rs8057620 | 69,884,619 | 0.46 | RP11-419C5.2 β | AFR - females | 0.035 | 2.27*10−9 | 0.024 | 4.40*10−10 | 1.79*10−17 | ++ |
chr16 | rs10584116 | 90,062,323 | 0.097 | C16orf3 β | TFR - females | −0.052 | 8.99*10−8 | −0.033 | 6.97*10−7 | 1.20*10−12 | −− |
chr17 | rs2071167 | 42,287,519 | 0.235 | ASB16 β | LFR - combined | −0.028 | 1.84*10−8 | −0.023 | 1.05*10−6 | 1.58*10−10 | −− |
chr17 | rs28394864 | 47,450,775 | 0.462 | ZNF652 α | TFR - females | −0.036 | 8.89*10−10 | −0.024 | 1.70*10−9 | 3.51*10−17 | −− |
chr19 | rs62621197 | 8,670,147 | 0.029 | ADAMTS10 δ | TFR - females | −0.105 | 2.17*10−9 | −0.147 | 3.45*10−39 | 8.33*10−46 | −− |
Lead SNP denotes the strongest associated SNP at each locus. The Most likely target gene column denotes a gene related to the associated locus either by proximity to the lead SNP (α), LD (R2 > 0.8) with a lead eQTL SNP for the gene (β) or LD (R2 > 0.8) with a missense variant within the gene (δ). β—effect size estimate per allele. Meta analyses were performed with METAL53. Direction—summary of effect direction for the discovery and replication cohorts, with one + or − per cohort. The Disc and Repl subscripts denote effects and P-values in the discovery and replication cohorts, respectively. PMeta denotes the P-value for meta analyses